Traveka Wealth, LLC Novartis Ag Transaction History
Traveka Wealth, LLC
- $205 Billion
- Q2 2024
A detailed history of Traveka Wealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Traveka Wealth, LLC holds 3,397 shares of NVS stock, worth $396,260. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,397
Previous 3,101
9.55%
Holding current value
$396,260
Previous $300 Million
20.55%
% of portfolio
0.18%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$865 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$864 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$694 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...